Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

NCT02729116 Phase 2/Phase 3 UNKNOWN

This study evaluates oral antimicrobial agents for the treatment of non-bacteremic acute urinary tract infection caused by Extended Spectrum Beta Lactamase producing Escherichia coli or Klebsiella pneumoniae in Post-kidney transplantation. Patients are treated with intravenous (IV) antibiotics follow by oral sitafloxacin or IV ertapenem.

Details

Lead sponsor	Khon Kaen University
Phase	Phase 2/Phase 3
Status	UNKNOWN
Enrolment	30
Start date	2016-07
Completion	2024-01

Conditions

• Anti-Infective Agents, Urinary
• Escherichia Coli Infections
• Klebsiella Infections
• Kidney Transplantation
• Urinary Tract Infections

Interventions

• Sitafloxacin
• Ertapenem

Primary outcomes

• Number of patients with clinical cure of acute urinary tract infection — 14 days
  No symptoms of acute urinary tract infection

Countries

Thailand